Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.
Introduction to the OPDC Parkinson's Open Day 2018

On Monday 10 September 2018, over 200 participants of the Discovery cohort were welcomed to an open afternoon of talks by OPDC scientists and clinicians to hear their latest research and share their views.

The event aimed to demonstrate to attendees how their participation is improving understanding of Parkinson's and driving the team closer to finding a cure.

DPAG Postdoctoral Research Scientist, Brent Ryan, gave a talk entitled "Screen your stem cell: Drug discovery for Parkinson's." A video of his talk can be viewed here.

The full story can be found on the OPDC website, where you can watch videos of all talks from the day.

 

OPDC September Open Day.png

Similar stories

The only way is UPP!

The OPDC is delighted to announce that Parkinson’s UK have agreed to fund a further four and a half years of ODPC Discovery Cohort follow-up from August 2021.

Physiology drawings enhance our understanding of the 'Amazing Body'

Visiting academic Dr Lizzie Burns received an outreach grant from The Physiological Society to create a novel set of engaging drawings for adult colouring-in to learn about our remarkable human body. Dr Burns has collaborated with members of The Society, including DPAG's Heidi de Wet, Peter Robbins, Keith Dorrington and Andrew King, to illustrate a wide range of physiological topics.

New laboratory space for OPDC Researchers

A major building in the centre of Oxford has been constructed to create a new research centre bringing together cellular neuroscience and physical sciences.

Dopamine neurons need a 'REST' in Parkinson’s Disease

A study led by University of Oxford researchers, Dr Brent Ryan and Dr Nora Bengoa-Vergniory has shown that the key protein RE1 Silencing Transcription Factor (REST) regulates the health of those neurons critically affected in Parkinson’s Disease.

Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease

A study led by the Oxford Parkinson’s Disease Centre’s (OPDC) Dr Nora Bengoa-Vergniory has shown that a novel assay termed the tau-proximity ligation assay is able to recognise Alzheimer’s disease before current detection methods.